HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 43 filers reported holding HEPION PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $18,370 | -100.0% | 61,175 | -43.3% | 0.08% | -61.6% |
| Q3 2022 | $54,518,000 | -52.2% | 107,915 | +7.8% | 0.21% | -49.4% |
| Q4 2021 | $114,101,000 | +43.4% | 100,089 | +92.5% | 0.42% | +75.2% |
| Q3 2021 | $79,543,000 | -78.8% | 51,989 | -72.6% | 0.24% | -79.6% |
| Q2 2021 | $375,439,000 | +1343.0% | 189,616 | +1241.0% | 1.17% | +1307.2% |
| Q1 2021 | $26,018,000 | – | 14,140 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 923,230 | $2,022,000 | 0.82% |
| Worth Venture Partners, LLC | 233,947 | $512,000 | 0.40% |
| PERKINS CAPITAL MANAGEMENT INC | 150,000 | $329,000 | 0.22% |
| GSA CAPITAL PARTNERS LLP | 89,067 | $195,000 | 0.03% |
| PREMIER ASSET MANAGEMENT LLC | 70,000 | $153,000 | 0.03% |
| Allen Capital Group, LLC | 23,685 | $52,000 | 0.01% |
| ZEKE CAPITAL ADVISORS, LLC | 50,000 | $110,000 | 0.01% |
| Prospera Financial Services Inc | 39,300 | $86,000 | 0.01% |
| Onex Canada Asset Management Inc. | 20,000 | $44,000 | 0.00% |
| Schonfeld Strategic Advisors LLC | 95,300 | $208,000 | 0.00% |